![]() |
||||
|
||||
|
|
||||
Re: endometrioma sclerotherapyFrom: art fougner, md (evsono@pipeline.com)Mon Mar 21 14:41:07 2005
No personal experience - here's an abstract that may be useful - Int J Gynaecol Obstet. 1997 Oct;59(1):31-4. Sclerotherapy--an adjuvant therapy to endometriosis. Chang CC, Lee HF, Tsai HD, Lo HY. Department of Obstetrics and Gynecology, China Medical College Hospital, Taiwan. OBJECTIVE: Recurrent endometriomas after medical or surgical treatment is a difficult clinical problem for those patients who wish to perform ovulation induction. Therefore we tried to investigate the efficacy of sclerotherapy as an adjuvant management before ovulation induction to preserve more ovarian tissue for folliculogenesis in ART program. METHODS: Thirty-two patients with persistent or recurrent endometrioma after surgical or medical treatment were included in this study. Transvaginal ultrasound needle guided aspiration of the cyst followed by tetracycline instillation was performed before ovulation induction. RESULTS: There is an encouraging clinical pregnancy rate of 34.37%. Also, there is a disappointing recurrent rate of 46.87% in 12 months follow-up course. CONCLUSION: The increased interest in cost-effective outpatient therapy and the expected difficulty in surgical treatment of recurrent endometriomas made aspiration and sclerotherapy of endometrioma an attractive option before ovulation induction. art
At Mon, 21 Mar 2005, Richard Chudacoff, MD wrote:
>
-- art fougner, md
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Jul 2 04:39:11 2008 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.